Demineralized bone matrix (DBM) is prepared from cortical bone that is derived from long bones. It is an allograft bone in which the inorganic mineral is removed and leaving behind the collagen matrix. The removal of the bone mineral exposes more biologically active bone morphogenetic proteins. Demineralized bone matrix is indicated to extend and strengthen the bone graft. This is due to the ability of growth factors to control the differentiation of progenitor cells, which are responsible for bone and cartilage formation. Demineralized bone matrix (DBM) is more biologically active as compared to mineralized bone grafts and aids in bone generation.
Market Dynamics
Key players operating in the global demineralized bone matrix market are focusing on adoption of growth strategies such as product launch and agreement, which is expected to boost the market growth during the forecast period. For instance, in July 2019, SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the product release of its OsteoStrand and OsteoStrand Plus demineralized bone fibers with its new integrated, hydration syringe system. Furthermore, in August 2018, BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, signed an agreement with MTF Biologics, the world’s largest tissue bank, to extend and strengthen its U.S. product offering. This agreement gave BONESUPPORT the U.S. rights to sell two forms of bone graft materials that are comprised of 100% demineralized bone matrix. BONESUPPORT launched the products supplied by MTF Biologics under BONESUPPORT brand name and distributed them through its own U.S. distribution network.
Key features of the study:
- This report provides in-depth analysis of the Global Demineralized Bone Matrix Market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Global Demineralized Bone Matrix Market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
- Key companies covered as a part of this study include Medtronic Plc, Johnson & Johnson (DePuy Synthes), Exactech, Inc., HansBioMed, Xtant Medical, Stryker, Arthrex GmbH, RTI Surgical, Zimmer Biomet., and Straumann
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The Global Demineralized Bone Matrix Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Demineralized Bone Matrix Market.
Detailed Segmentation:
- Global Demineralized Bone Matrix Market, By Type :
- Gel
- Putty
- Putty with Chips
- Others
- Global Demineralized Bone Matrix Market, By Applications:
- Dental
- Spine Surgery
- Trauma Surgery
- Global Demineralized Bone Matrix Market, By End User:
- Hospitals
- Specialty Clinics
- Others
- Global Demineralized Bone Matrix Market, By Region:
- North America
- By Type
- Gel
- Putty
- Putty with Chips
- Others
- By Applications
- Dental
- Spine Surgery
- Trauma Surgery
- By End User
- Hospitals
- Specialty Clinics
- Others
- By Country
- Latin America
- By Type
- Gel
- Putty
- Putty with Chips
- Others
- By Applications
- Dental
- Spine Surgery
- Trauma Surgery
- By End User
- Hospitals
- Specialty Clinics
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Type
- Gel
- Putty
- Putty with Chips
- Others
- By Applications
- Dental
- Spine Surgery
- Trauma Surgery
- By End User
- Hospitals
- Specialty Clinics
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Type
- Gel
- Putty
- Putty with Chips
- Others
- By Applications
- Dental
- Spine Surgery
- Trauma Surgery
- By End User
- Hospitals
- Specialty Clinics
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Type
- Gel
- Putty
- Putty with Chips
- Others
- By Applications
- Dental
- Spine Surgery
- Trauma Surgery
- By End User
- Hospitals
- Specialty Clinics
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Type
- Gel
- Putty
- Putty with Chips
- Others
- By Applications
- Dental
- Spine Surgery
- Trauma Surgery
- By End User
- Hospitals
- Specialty Clinics
- Others
- By Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Medtronic Plc*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson (DePuy Synthes)
- Exactech, Inc.
- HansBioMed
- Xtant Medical
- Stryker
- Arthrex GmbH
- RTI Surgical
- Zimmer Biomet
- Straumann
“*” marked represents similar segmentation in other categories in the respective section.
